1. Identification of Insulin-Like Growth Factor Binding Protein-3 as a Farnesyl Transferase Inhibitor SCH66336-Induced Negative Regulator of Angiogenesis in Head and Neck Squamous Cell Carcinoma
   Seung-Hyun Oh et al, 2006, Clinical Cancer Research CrossRef
2. Phase II Trial of Tipifarnib plus Neoadjuvant Doxorubicin-Cyclophosphamide in Patients with Clinical Stage IIB-IIIC Breast Cancer
   Joseph A. Sparano et al, 2009, Clinical Cancer Research CrossRef